Canada · Health Canada Drug Product Database

PEGALAX

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
81376
DIN
02328232
Form
Powder For Solution
Company as listed by source
ARALEZ PHARMACEUTICALS CANADA INC
Source status
Cancelled Post Market (2023-08-03)
Source last updated
2025-03-22

Source-listed ingredients

  • POLYETHYLENE GLYCOL 3350 — 100 % — per 1 W/W

These values do not establish equivalence or a dose recommendation.

Packages

  • 17g Satchet (14 Per Carton)

Source and coverage

Open Health Canada Drug Product Database

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →
PEGALAX — Canada | Molindra Medicines